A Cortical Pathogenic Theory of Parkinson's Disease

被引:110
|
作者
Foffani, Guglielmo [1 ,2 ]
Obeso, Jose A. [1 ,3 ]
机构
[1] Univ CEU San Pablo, Hosp Univ HM Puerta Sur, CINAC, Madrid, Spain
[2] Hosp Nacl Paraplej, Toledo, Spain
[3] Inst Salud Carlos III, CIBERNED, Madrid, Spain
关键词
TRANSCRANIAL MAGNETIC STIMULATION; LEVODOPA-INDUCED DYSKINESIAS; STRIATAL PROJECTION NEURONS; EARLY SYNAPTIC DYSFUNCTION; ALPHA-SYNUCLEIN; BASAL GANGLIA; DOPAMINE RELEASE; MOTOR CORTEX; COMPENSATORY MECHANISMS; CORTICOSPINAL NEURONS;
D O I
10.1016/j.neuron.2018.07.028
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic neurons in the substantia nigra pars compacta (SNc) is associated with classic motor features, which typically have a focal onset. Since a defined somatotopic arrangement in the SNc has not been recognized, this focal motor onset is unexplained and hardly justified by current pathogenic theories of bottom-up disease progression (Braak's hypothesis, prionopathy). Here we propose that corticostriatal activity may represent a critical somatotopic "stressor'' for nigrostriatal terminals, ultimately driving retrograde nigrostriatal degeneration and leading to focal motor onset and progression of Parkinson's disease. As a pathogenic mechanism, corticostriatal activity may promote secretion of striatal extracellular alpha-synuclein, favoring its pathological aggregation at vulnerable dopaminergic synapses. A similar pathogenic process may occur at corticofugal projections to the medulla oblongata and other vulnerable structures, thereby contributing to the bottom-up progression of Lewy pathology. This cortical pathogenesis may co-exist with bottom-up mechanisms, adding an integrative top-down perspective to the quest for the factors that impinge upon the vulnerability of dopaminergic cells in the onset and progression of Parkinson's disease.
引用
收藏
页码:1116 / 1128
页数:13
相关论文
共 50 条
  • [31] Mirror writing and cortical hypometabolism in Parkinson's disease
    Shinohara, Mayumi
    Yokoi, Kayoko
    Hirayama, Kazumi
    Kanno, Shigenori
    Hosokai, Yoshiyuki
    Nishio, Yoshiyuki
    Ishioka, Toshiyuki
    Otsuki, Mika
    Takeda, Atsushi
    Baba, Toru
    Aoki, Masashi
    Hasegawa, Takafumi
    Kikuchi, Akio
    Narita, Wataru
    Mori, Etsuro
    Suzuki, Kyoko
    PLOS ONE, 2022, 17 (12):
  • [32] Enhanced sensory cortical excitability in Parkinson's disease
    Wu, Z-A.
    Liao, K-K.
    JOURNAL OF NEUROLOGY, 2008, 255 : 97 - 97
  • [33] Interhemispheric differences in cortical excitability in Parkinson's disease
    Kim, S. D.
    Fung, V. S. C.
    Kiernan, M. C.
    Vucic, S.
    MOVEMENT DISORDERS, 2011, 26 : S38 - S39
  • [34] Loss of Cortical Gray Matter in Parkinson's Disease
    Sen, Suman
    Eslinger, Paul J.
    Wagner, Daymond
    Du, Guangwei
    Lewis, Mechelle M.
    Shaffer, Michel L.
    Huang, Xuemei
    ANNALS OF NEUROLOGY, 2011, 70 : S16 - S16
  • [35] Illusory Misidentifications and Cortical Hypometabolism in Parkinson's Disease
    Ishioka, Toshiyuki
    Hirayama, Kazumi
    Hosokai, Yoshiyuki
    Takeda, Atsushi
    Suzuki, Kyoko
    Nishio, Yoshiyuki
    Sawada, Yoichi
    Takahashi, Shoki
    Fukuda, Hiroshi
    Itoyama, Yasuto
    Mori, Etsuro
    MOVEMENT DISORDERS, 2011, 26 (05) : 837 - 843
  • [36] The cortical signature of symptom laterality in Parkinson's disease
    Heinrichs-Graham, Elizabeth
    Santamaria, Pamela M.
    Gendelman, Howard E.
    Wilson, Tony W.
    NEUROIMAGE-CLINICAL, 2017, 14 : 433 - 440
  • [37] Neuroinflammation in alzheimer's disease and Parkinson's disease: Are microglia pathogenic in either disorder?
    Rogers, Joseph
    Mastroeni, Diego
    Leonard, Brian
    Joyce, Jeffrey
    Grover, Andrew
    NEUROINFLAMMATION IN NEURONAL DEATH AND REPAIR, 2007, 82 : 235 - 246
  • [38] Parkinson's Disease-Specific Cortical Atrophy As An Independent Contributor To Motor Symptom In Parkinson's Disease
    Kang, S. W.
    Yoo, H. S.
    Lyoo, C. L.
    MOVEMENT DISORDERS, 2023, 38 : S103 - S103
  • [39] Non-CNS pathogenic origin of Parkinson's disease
    Choudhry, Humdoon
    Perlmuter, Lawrence C.
    JOURNAL OF NEUROLOGY, 2017, 264 (09) : 2027 - 2030
  • [40] The role of aldehyde dehydrogenase on the pathogenic mechanism of Parkinson's disease
    Yeh, T. H.
    Chiu, C. C.
    Wang, H. L.
    Lai, S. C.
    Chang, H. C.
    Chen, Y. J.
    Chen, C. H.
    Mochly-Rosen, D.
    Lu, C. S.
    MOVEMENT DISORDERS, 2013, 28 : S365 - S365